The table below shows BIOMARIN PHARMACEUTICAL INC's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$766.21M
$776.13M
$825.41M
$745.14M
$745.74M
$712.03M
Cost of revenue
$195.00M
$140.09M
$150.09M
$151.56M
$188.46M
$130.46M
Gross profit
-
-
-
-
-
-
R&D
$178.80M
$409.48M
$161.31M
$158.73M
$184.90M
$183.79M
BMRN annual revenue (10-K history)
BIOMARIN PHARMACEUTICAL INC reported annual revenue of $3.22B for fiscal year 2025. That is up 12.9% from $2.85B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $1.12B (FY 2016) to $3.22B. Figures come from the company's audited annual reports as filed with the SEC.
